Evaluation of bivalirudin-based anticoagulation for extracorporeal membrane oxygenation, including patients with COVID-19

Background: Although unfractionated heparin (UFH) has traditionally been used for anticoagulation during extracorporeal membrane oxygenation (ECMO), bivalirudin may be preferred due to fewer complications. A prior medication use evaluation of ECMO patients who received bivalirudin resulted in dosing...

Description complète

Détails bibliographiques

Auteurs principaux:	Raguindin Miranda, Bardsley Casey, Bast Chelsea, Sugrue David, Kazmi Hasan, Milkovits Ashley
Format:	Artigo
Langue:	Inglês
Publié:	EDP Sciences 2026-03-01
Collection:	The Journal of ExtraCorporeal Technology
Sujets:	ecmo (extracorporeal membrane oxygenation) bivalirudin pharmacology acute respiratory distress syndrome (ards) covid-19
Accès en ligne:	https://ject.edpsciences.org/articles/ject/full_html/2026/01/ject250056/ject250056.html
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!